Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | PSEN1 | P49768 | 9/20 | 0.38 |
| ▸ | PSEN2 | P49810 | 9/20 | 0.38 |
| ▸ | APH1B | Q8WW43 | 9/20 | 0.38 |
| ▸ | NCSTN | Q92542 | 9/20 | 0.38 |
| ▸ | APH1A | Q96BI3 | 9/20 | 0.38 |
| ▸ | PSENEN | Q9NZ42 | 9/20 | 0.38 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14438275 | 0.80 | MEN1 (0.43) | MEN1CYP3A4KMT2ACYP1A2CYP2D6 | |
| SCHEMBL2647752 | 0.80 | MEN1 (0.57) | MEN1CYP3A4KMT2ACYP1A2CYP2D6 | |
| SCHEMBL21346321 | 0.79 | KCNH2 (0.41) | MEN1CYP3A4KMT2ACYP1A2CYP2D6 | |
| SCHEMBL25454248 | 0.77 | CYP1A2 (0.44) | MEN1CYP3A4KMT2ACYP1A2CYP2D6 | |
| SCHEMBL19862553 | 0.77 | CXCR3 (0.43) | MEN1CYP3A4KMT2ACYP1A2CYP2D6 | |
| SCHEMBL29493203 | 0.77 | IDO1 (0.50) | MEN1CYP3A4KMT2ACYP1A2CYP2C9 | |
| SCHEMBL1154758 | 0.77 | IDO1 (0.50) | MEN1CYP3A4KMT2ACYP1A2CYP2C9 | |
| SCHEMBL16363482 | 0.76 | BCHE (0.51) | KMT2APOLBKDM4ELMNA | |
| SCHEMBL21345583 | 0.75 | LMNA (0.47) | MEN1KMT2ACYP1A2CYP2D6MAPT | |
| SCHEMBL3127354 | 0.74 | TYR (0.42) | MEN1CYP3A4KMT2APOLBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230143470-A1 | SMALL MOLECULE INHIBITORS OF INFLUENZA HEMAGGLUTININ | NATIONAL INSTITUTES OF HEALTH | 2023-05-11 | — | — | US | disclosed |
| US-20230143470-A1 | SMALL MOLECULE INHIBITORS OF INFLUENZA HEMAGGLUTININ | NATIONAL INSTITUTES OF HEALTH | 2023-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230143470-A1 | SMALL MOLECULE INHIBITORS OF INFLUENZA HEMAGGLUTININ | HAVCR2, CD44, ENGASE | MEN1 4309/4885CYP3A4 4671/4885KMT2A 2659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.